Clinical Trials in San Francisco

Showing 6801-6820 of 9,883 trials

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and thalidomide in treating patients who have recurrent or progressive brain tumor.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 participantsStarted Jun 2000

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +8 more locations

COMPLETEDEARLY Phase 1< 1 mile

Fecal Microbiota Transplant for Inflammatory Bowel Disease

NCT02460705

Currently enrolling only patients with Ulcerative Colitis. Enrollment and experimental treatment of patients with Crohn's Disease stopped for a safety evaluation. This is a prospective, open label pilot study in which patients with symptoms of Inflammatory bowel disease will receive FMT therapy delivered via colonoscopy. The investigators hypothesize that FMT is a safe and effective treatment for patients with inflammatory bowel disease. The aims are: 1. To determine if symptoms of inflammatory bowel disease can be successfully treated by Fecal Microbial Transplantation. 2. To determine if endoscopic appearance of colon or ileum improves following treatment by Fecal Microbial Transplantation.

Inflammatory Bowel Disease

University of California, San Francisco59 participantsStarted Jun 2015

San Francisco, California, United States

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Fecal Microbiota Transplant for Inflammatory Bowel Disease

Find Trials by Condition in San Francisco

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Evaluation of the Accuracy of an Implanted Glucose Sensor

An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas

Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Phase III Cat-PAD Study

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Evaluation of Etafilcon A Daily Disposable Lenses